BIO 2025 this year came at a uniquely fraught moment for vaccination in the United States just days after HHS Secretary ...

Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly ...

Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of ...

From the practical wisdom of emphasising exercise to improve survival in colon cancer to the association of glucagon-like ...

However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...

ASCO 2025 may be over, but the insights are just beginning. This “Spotlight On” page is your hub for ongoing post-event coverage, including expert interviews, key takeaways, and video content ...

New research reveals some significant imbalances between healthcare professionals' (HCP) demand and industry's provision of medical information, based on content types, channels and format.

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased. Ben Hargreaves speaks to an expert in the area to learn how ...

Acadia Pharma's attempts to extend the indications of its Nuplazid drug in the US to include Alzheimer's disease-related psychosis have suffered another major setback. Nuplazid (pimavanserin) is ...

The biopharma industry faces a relentless demand for evidence of real-world effectiveness (RWE), safety, and value throughout the product lifecycle to complement the clinical trial-based benefit ...

Robert F Kennedy Jr and Donald Trump speaking with attendees at an Arizona for Trump rally at Desert Diamond Arena in Glendale, Arizona in 2024 President Trump's pick to lead the Department of ...

As the demands of modern healthcare grow, new therapies are introduced at record speeds, and guidelines are quickly updated, it is key that medical education evolves to keep up. Traditional ...